{
    "clinical_study": {
        "@rank": "89165", 
        "acronym": "SIMETOL", 
        "arm_group": [
            {
                "arm_group_label": "Physiotherapy", 
                "arm_group_type": "Active Comparator", 
                "description": "Traditional techniques"
            }, 
            {
                "arm_group_label": "simeox", 
                "arm_group_type": "Experimental", 
                "description": "Medical device"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether the medical device \"simeox\" is safe in the\n      treatment of respiratory diseases, in comparison with traditional physiotherapy."
        }, 
        "brief_title": "Evaluation of the Safety of the Medical Device Simeox\u00ae", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Broncho-degenerative Disease", 
            "Chronic Obstructive Airway Disease", 
            "Cystic Fibrosis", 
            "Idiopathic Bronchiectasis", 
            "Ciliary Dyskinesia", 
            "Chronic Bronchitis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Bronchiectasis", 
                "Bronchitis", 
                "Bronchitis, Chronic", 
                "Ciliary Motility Disorders", 
                "Cystic Fibrosis", 
                "Dyskinesias", 
                "Fibrosis", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient over 18, male or female.\n\n          -  Patient affected by broncho-degenerative disease, chronic obstructive airway disease,\n             cystic fibrosis, idiopathic bronchiectasis, ciliary dyskinesia and/or chronic\n             bronchitis.\n\n          -  Hospitalization for a minimum of five days or a maximum of 8 days.\n\n          -  Bronchial clearance is usually productive.\n\n          -  FVC and / or FEV <85% predicted, with stable lung function.\n\n          -  Agreement to participate to the study and signature of the informed consent form\n\n          -  Social security coverage.\n\n        Exclusion Criteria:\n\n          -  Patient infected with bacteria resistant to antibiotics.\n\n          -  Bronchial clearance is not usually productive.\n\n          -  Patient with contra-indication for physiotherapy bronchial clearance.\n\n          -  Patient who received a lung transplant.\n\n          -  Care requires more than 2 sessions of chest physiotherapy daily.\n\n          -  Duration of mechanical ventilation > 8h/day.\n\n          -  Patient with an episode of hemoptysis during the month before inclusion.\n\n          -  Patient with an episode of pneumothorax during the last month.\n\n          -  Pregnant or lactating women.\n\n          -  Patient with a disability and/or unwillingness to follow protocol requirements.\n\n          -  Patient participating in another clinical study or having tested an experimental drug\n             within 30 days prior to his inclusion in the study.\n\n          -  Patient ( s) with another condition which, according to the investigator , may\n             interfere with the result or conduct of the trial and thus justify their non-\n             inclusion in the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 31, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02061852", 
            "org_study_id": "2014-A00079-38"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Physiotherapy", 
                    "simeox"
                ], 
                "intervention_name": "Simeox", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": [
                    "Physiotherapy", 
                    "simeox"
                ], 
                "intervention_name": "Physiotherapy", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 11, 2014", 
        "location": {
            "contact": {
                "email": "martine.reynaud@ap-hm.fr", 
                "last_name": "Martine REYNAUD-GAUBERT, Prof.", 
                "phone": "+ 334 91 96 61 45"
            }, 
            "facility": {
                "address": {
                    "city": "Marseille", 
                    "country": "France", 
                    "zip": "13915 Cedex 20"
                }, 
                "name": "CHU Nord"
            }, 
            "investigator": {
                "last_name": "Martine REYNAUD-GAUBERT, Prof.", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prospective Trial for the Evaluation of Safety, Tolerability and Efficacy of the Medical Device Simeox \u00ae Compared to Traditional Respiratory Physiotherapy Techniques for Airway Secretion Clearance", 
        "overall_official": {
            "affiliation": "Hospital Marseille", 
            "last_name": "Martine Reynaud-Gaubert, Prof.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Adverse events related or not to the simeox\u00ae", 
            "measure": "Safety of the simeox\u00ae", 
            "safety_issue": "Yes", 
            "time_frame": "Day 8"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02061852"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Physio-Assist", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Mediaclin", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "University Hospital, Marseille", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Physio-Assist", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}